Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Assist in the development, design, review, and delivery of healthcare compliance related policies, SOPs, and trainings, all consistent with current regulatory guidance and industry best practices (e.g., PhRMA Code, OIG guidance, aggregate spend, third-party funding, sampling, code of conduct).